The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...
Wharton hopes that reframing obesity as a disease will help move away from people with larger body sizes being judged for their weight. Diabetes Canada, American Heart Association and Take Off ...
Wharton hopes that reframing obesity as a disease will help move away from people with larger body sizes being judged for their weight. Diabetes Canada, American Heart Association and Take Off Pounds ...